Anthropic drops 400 million in shares on an eight-month-old AI pharma startup with fewer than ten employees
Anthropic acquires AI pharma startup Coefficient Bio for $400 million.
Anthropic has made a significant move by acquiring AI biotech startup Coefficient Bio for approximately $400 million in shares. Founded just eight months ago with a small team, Coefficient Bio developed a platform to enhance pharmaceutical tasks such as drug research planning. The acquisition is likely driven by Anthropic's interest in Coefficient Bio's specialized talent to accelerate its healthcare initiatives.
Key Takeaways
- 1.
Coefficient Bio was founded just eight months ago and has fewer than ten employees.
- 2.
Dimension, a venture capital firm, reported a 38,513 percent return on its investment in Coefficient Bio.
- 3.
Anthropic's acquisition comes amid increasing AI efforts in the pharmaceutical industry.
Get your personalized feed
Trace groups the biggest stories, videos, and discussions into one feed so you can stay current without scanning ten tabs.
Try Trace free